Download FREE Report Sample
Download Free sampleSemaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. Semaglutide injection is used to treat type 2 diabetes. It is used together with diet and exercise to help control your blood sugar. This medicine is also used to lower the risk of heart attack, stroke, or death in patients with type 2 diabetes and heart or blood vessel disease. This medicine is also used together with diet and exercise to help lose weight and keep the weight off in patients with obesity caused by certain conditions.
Semaglutide Injection Market contains market size and forecasts of Semaglutide Injection in global, including the following market information:
Global Semaglutide Injection Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global Semaglutide Injection Market Sales, 2018-2023, 2023-2030, (K Units)
Global top five Semaglutide Injection companies in 2022 (%)
The global Semaglutide Injection market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Dosage: 1.5ML Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Semaglutide Injection include Novo Nordisk. etc. In 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Semaglutide Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Semaglutide Injection Market, by Type, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Semaglutide Injection Market Segment Percentages, by Type, 2022 (%)
Dosage: 1.5ML
Dosage: 3 ML
Global Semaglutide Injection Market, by Application, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Semaglutide Injection Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Global Semaglutide Injection Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Semaglutide Injection Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Semaglutide Injection revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Semaglutide Injection revenues share in global market, 2022 (%)
Key companies Semaglutide Injection sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Semaglutide Injection sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novo Nordisk
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
